Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 2/2016

01-06-2016 | Original Article

Diabetes mellitus and its risk factors among a middle-aged population of Iran, a population-based study

Authors: Hossein Ebrahimi, Mohammad Hassan Emamian, Mohammad Shariati, Hassan Hashemi, Akbar Fotouhi

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2016

Login to get access

Abstract

Diabetes is a major health problem around the world. The risk of diabetes is increasing worldwide, and its misdiagnosis may have significant public health implications. This study aimed to determine the prevalence of diabetes and its risk factors among the middle-aged population in Shahroud, north of Iran. In the present study, the plasma glucose levels in 5190 subjects aged 40–64 years, participating in the first phase of the Shahroud Eye Cohort Study in 2009, were measured. Non-fasting glucose level greater than or equal to 200 mg/dl and/or the use of blood glucose-lowering drugs were considered as criteria for the diagnosis of diabetes. To determine the risk factors associated with diabetes, simple and multivariate logistic regressions were used. The prevalence of diabetes in men, women, and the total population were 10.4, 13.6, and 12.3 %, respectively. The mean blood glucose levels in men and women were 116.7 and 117.3 mg/dl, respectively. Age (odds ratio (OR) = 1.04), hypertension (OR = 2.5), being overweight (OR = 1.5), and obesity (OR = 1.5) were positively associated with diabetes. In addition, having an insurance (OR = 0.48) and male gender (OR = 0.81) was associated with a reduced risk of diabetes. Based on the results of the present study, the prevalence of diabetes in the studied population is high, and according to the epidemiological transition of diseases, a high percentage of the Iranian population are at risk for cardiovascular diseases. Considering the risk factors identified in the present study, developing effective interventions is essential.
Literature
1.
go back to reference International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels: International Diabetes Federation; 2013. International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels: International Diabetes Federation; 2013.
2.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed
3.
go back to reference Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.CrossRefPubMed Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.CrossRefPubMed
4.
go back to reference Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8:228–36.CrossRef Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8:228–36.CrossRef
5.
go back to reference Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.CrossRefPubMed Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.CrossRefPubMed
6.
go back to reference Boyko EJ, Jacobson IG, Smith B, Ryan MAK, Hooper TI, Amoroso PJ, et al. Risk of diabetes in U.S. military service members in relation to combat deployment and mental health. Diabetes Care. 2010;33:1771–7.CrossRefPubMedPubMedCentral Boyko EJ, Jacobson IG, Smith B, Ryan MAK, Hooper TI, Amoroso PJ, et al. Risk of diabetes in U.S. military service members in relation to combat deployment and mental health. Diabetes Care. 2010;33:1771–7.CrossRefPubMedPubMedCentral
7.
go back to reference Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran. Iran Diabetol. 2009;52:1520–7.CrossRef Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran. Iran Diabetol. 2009;52:1520–7.CrossRef
8.
go back to reference Barcelo A, Aedo C, Rajpathak S, Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ. 2003;81:19–27.PubMedPubMedCentral Barcelo A, Aedo C, Rajpathak S, Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ. 2003;81:19–27.PubMedPubMedCentral
9.
go back to reference Franse LV, Di Bari M, Shorr RI, Resnick HE, van Eijk JT, Bauer DC, et al. Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the health, aging, and body composition study. Diabetes Care. 2001;24:2065–70.CrossRefPubMed Franse LV, Di Bari M, Shorr RI, Resnick HE, van Eijk JT, Bauer DC, et al. Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the health, aging, and body composition study. Diabetes Care. 2001;24:2065–70.CrossRefPubMed
10.
go back to reference Global health risks. Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009. Global health risks. Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
12.
go back to reference Alwan A. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011. Alwan A. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
13.
go back to reference Malekzadeh R. Global Burden of Disease Study 2010: a real advance in global descriptive epidemiology: prospective for developing countries. Arch Iran Med. 2014;17:302–3.PubMed Malekzadeh R. Global Burden of Disease Study 2010: a real advance in global descriptive epidemiology: prospective for developing countries. Arch Iran Med. 2014;17:302–3.PubMed
14.
go back to reference Naghavi M, Shahraz S, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, et al. Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med. 2014;17:321–35.PubMed Naghavi M, Shahraz S, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, et al. Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med. 2014;17:321–35.PubMed
15.
go back to reference Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F, et al. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med. 2014;17:304–20.PubMed Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F, et al. Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med. 2014;17:304–20.PubMed
16.
go back to reference Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Azizi F. Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran lipid and glucose study. J Endocrinol Invest. 2012;35:14–20.PubMed Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Azizi F. Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran lipid and glucose study. J Endocrinol Invest. 2012;35:14–20.PubMed
17.
go back to reference Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Ghanbarian A, Azizi F. Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality. Cardiovasc Diabetol. 2012;11:69.CrossRefPubMedPubMedCentral Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Ghanbarian A, Azizi F. Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality. Cardiovasc Diabetol. 2012;11:69.CrossRefPubMedPubMedCentral
18.
go back to reference Jarrett RJ. Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus. Epidemiol Rev. 1989;11:151–71.PubMed Jarrett RJ. Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus. Epidemiol Rev. 1989;11:151–71.PubMed
19.
go back to reference Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract. 2014;103:319–27.CrossRefPubMed Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract. 2014;103:319–27.CrossRefPubMed
20.
go back to reference Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31:96–8.CrossRefPubMed Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31:96–8.CrossRefPubMed
21.
go back to reference Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167.CrossRefPubMedPubMedCentral Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167.CrossRefPubMedPubMedCentral
22.
go back to reference Fotouhi A, Hashemi H, Shariati M, Emamian MH, Yazdani K, Jafarzadehpur E, et al. Cohort profile: Shahroud eye cohort study. Int J Epidemiol. 2013;42:1300–8.CrossRefPubMed Fotouhi A, Hashemi H, Shariati M, Emamian MH, Yazdani K, Jafarzadehpur E, et al. Cohort profile: Shahroud eye cohort study. Int J Epidemiol. 2013;42:1300–8.CrossRefPubMed
23.
go back to reference American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36:S11–66.CrossRef American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36:S11–66.CrossRef
24.
go back to reference Mahan LK, Escott-Stump S, Raymond JL. Krause’s food, nutrition and diet therapy. 13th ed. Philadelphia: WB Saunders; 2012. Mahan LK, Escott-Stump S, Raymond JL. Krause’s food, nutrition and diet therapy. 13th ed. Philadelphia: WB Saunders; 2012.
25.
go back to reference Eskandarian R, Rashidiypour A, Raheb G, Malek M. Epidemiology of diabetes and impaired fasting glucose in adults in the province. Iran J Diabet Lipid. 2009;8:375–82. Eskandarian R, Rashidiypour A, Raheb G, Malek M. Epidemiology of diabetes and impaired fasting glucose in adults in the province. Iran J Diabet Lipid. 2009;8:375–82.
26.
go back to reference Lee CM, Huxley RR, Lam TH, Martiniuk AL, Ueshema H, Pan WH, et al. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. Asia Pac J Clin Nutr. 2007;16:187–92.PubMed Lee CM, Huxley RR, Lam TH, Martiniuk AL, Ueshema H, Pan WH, et al. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. Asia Pac J Clin Nutr. 2007;16:187–92.PubMed
27.
go back to reference Forouhi NG, Merrick D, Goyder E, Ferguson BA, Abbas J, Lachowycz K, et al. Diabetes prevalence in England, 2001—estimates from an epidemiological model. Diabet Med. 2006;23:189–97.CrossRefPubMed Forouhi NG, Merrick D, Goyder E, Ferguson BA, Abbas J, Lachowycz K, et al. Diabetes prevalence in England, 2001—estimates from an epidemiological model. Diabet Med. 2006;23:189–97.CrossRefPubMed
28.
go back to reference Rathmann W, Scheidt-Nave C, Roden M, Herder C. Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction. Deutsches Arzteblatt Int. 2013;110:331–7. Rathmann W, Scheidt-Nave C, Roden M, Herder C. Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction. Deutsches Arzteblatt Int. 2013;110:331–7.
29.
go back to reference Coppell KJ, Mann JI, Williams SM, Jo E, Drury PL, Miller JC, et al. Prevalence of diagnosed and undiagnosed diabetes and prediabetes in New Zealand: findings from the 2008/09 adult nutrition survey. N Z Med J. 2013;126:23–42.PubMed Coppell KJ, Mann JI, Williams SM, Jo E, Drury PL, Miller JC, et al. Prevalence of diagnosed and undiagnosed diabetes and prediabetes in New Zealand: findings from the 2008/09 adult nutrition survey. N Z Med J. 2013;126:23–42.PubMed
30.
go back to reference Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: national health and nutrition examination survey 1999–2002. Diabetes Care. 2006;29:1263–8.CrossRefPubMed Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: national health and nutrition examination survey 1999–2002. Diabetes Care. 2006;29:1263–8.CrossRefPubMed
31.
go back to reference Hammami S, Mehri S, Hajem S, Koubaa N, Souid H, Hammami M. Prevalence of diabetes mellitus among non institutionalized elderly in Monastir City. BMC Endocr Disord. 2012;12:15.CrossRefPubMedPubMedCentral Hammami S, Mehri S, Hajem S, Koubaa N, Souid H, Hammami M. Prevalence of diabetes mellitus among non institutionalized elderly in Monastir City. BMC Endocr Disord. 2012;12:15.CrossRefPubMedPubMedCentral
32.
go back to reference Al Ali R, Mzayek F, Rastam S, Fouad FM, O'Flaherty M, Capewell S, et al. Forecasting future prevalence of type 2 diabetes mellitus in Syria. BMC Public Health. 2013;13:507.CrossRefPubMedPubMedCentral Al Ali R, Mzayek F, Rastam S, Fouad FM, O'Flaherty M, Capewell S, et al. Forecasting future prevalence of type 2 diabetes mellitus in Syria. BMC Public Health. 2013;13:507.CrossRefPubMedPubMedCentral
33.
go back to reference Albache N, Al Ali R, Rastam S, Fouad FM, Mzayek F, Maziak W. Epidemiology of type 2 diabetes mellitus in Aleppo. Syria J Diabet. 2010;2:85–91.CrossRef Albache N, Al Ali R, Rastam S, Fouad FM, Mzayek F, Maziak W. Epidemiology of type 2 diabetes mellitus in Aleppo. Syria J Diabet. 2010;2:85–91.CrossRef
34.
go back to reference Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378:31–40.CrossRefPubMed Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378:31–40.CrossRefPubMed
35.
go back to reference Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49:571–6.PubMed Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49:571–6.PubMed
36.
go back to reference Maier W, Holle R, Hunger M, Peters A, Meisinger C, Greiser KH, et al. The impact of regional deprivation and individual socio-economic status on the prevalence of type 2 diabetes in Germany. A pooled analysis of five population-based studies. Diabet Med. 2013;30:e78–86.CrossRefPubMed Maier W, Holle R, Hunger M, Peters A, Meisinger C, Greiser KH, et al. The impact of regional deprivation and individual socio-economic status on the prevalence of type 2 diabetes in Germany. A pooled analysis of five population-based studies. Diabet Med. 2013;30:e78–86.CrossRefPubMed
37.
go back to reference Onat A, Hergenç G, Uyarel H, Can G, Ozhan H. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anatolian J Cardiol. 2006;6:314–21. Onat A, Hergenç G, Uyarel H, Can G, Ozhan H. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anatolian J Cardiol. 2006;6:314–21.
38.
go back to reference Shrestha UK, Singh DL, Bhattarai MD. The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal. Diabet Med. 2006;23:1130–5.CrossRefPubMed Shrestha UK, Singh DL, Bhattarai MD. The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal. Diabet Med. 2006;23:1130–5.CrossRefPubMed
Metadata
Title
Diabetes mellitus and its risk factors among a middle-aged population of Iran, a population-based study
Authors
Hossein Ebrahimi
Mohammad Hassan Emamian
Mohammad Shariati
Hassan Hashemi
Akbar Fotouhi
Publication date
01-06-2016
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2016
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0397-x

Other articles of this Issue 2/2016

International Journal of Diabetes in Developing Countries 2/2016 Go to the issue

Editorial Note

Editorial

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.